SELLAS Life Sciences (SLS) Cash & Current Investments (2010 - 2026)
SELLAS Life Sciences (SLS) posted quarterly Cash & Current Investments of $107.1 million for Q1 2026, up 107000.0% year-over-year from N/an in Q1 2025, and up 107000.0% quarter-over-quarter from $100000.0 in Q4 2025.
SELLAS Life Sciences (SLS) Cash & Current Investments (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Cash & Current Investments for 17 consecutive years, with $107.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments rose 107000.0% year-over-year to $107.1 million; the TTM figure through Mar 2026 stood at $107.1 million (up 107000.0% YoY), while the FY2025 annual figure was $100000.0, down 99.28% from the prior year.
- Cash & Current Investments grew to $107.1 million in Q1 2026 per SLS's latest filing, from $100000.0 in the prior quarter.
- Across five years, Cash & Current Investments topped out at $107.1 million in Q1 2026 and bottomed at $100000.0 in Q1 2022.
- Historically, Cash & Current Investments has averaged $15.7 million across 5 years, with a median of $4.0 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments sank 99.62% — and 2026, when it soared 107000.0%.
- SELLAS Life Sciences' Cash & Current Investments stood at $17.1 million in 2022, then slumped by 99.42% to $100000.0 in 2023, then surged by 13786.0% to $13.9 million in 2024, then tumbled by 99.28% to $100000.0 in 2025, then jumped by 107000.0% to $107.1 million in 2026.
- Business Quant data shows SLS's Cash & Current Investments at $107.1 million in Q1 2026, $100000.0 in Q4 2025, and $44.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 836.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.16 Bn |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | 138.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138.34 Mn |
| Mar 31, 2026 | 107.10 Mn |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 44.30 Mn |
| Jun 30, 2025 | 25.30 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 13.89 Mn |
| Sep 30, 2024 | 21.03 Mn |
| Jun 30, 2024 | 9.10 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 23.90 Mn |
| Dec 31, 2022 | 17.13 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 26.28 Mn |